Latanoprost Actavis

Latanoprost, the active ingredient in Latanoprost Actavis, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It lowers intra‑ocular pressure in adults with open‑angle glaucoma or ocular hypertension by increasing fluid outflow from the eye, helping to preserve visual function.

GNH USA supplies Latanoprost Actavis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution.

Latanoprost is a prostaglandin analog used to lower intra‑ocular pressure in glaucoma‑related conditions.

Open‑angle glaucoma: reduces intra‑ocular pressure to slow disease progression. Ocular hypertension: lowers eye pressure to prevent development of glaucoma. Secondary open‑angle glaucoma: helps control pressure when other causes are present. Normal‑tension glaucoma: assists in maintaining target pressure to protect optic nerve health.

Latanoprost may cause ocular and systemic reactions, most of which are mild and reversible.

Common Side Effects: - Eye redness or hyperemia. - Increased eyelash length and density. - Darkening of the iris color. - Eye irritation or foreign‑body sensation. - Blurred vision shortly after instillation. - Mild eye pain or discomfort.

Serious or Rare Side Effects: - Severe allergic reaction with swelling of the eyelid or conjunctiva. - Uveitis or intra‑ocular inflammation. - Macular edema leading to visual disturbance. - Persistent eye pain unresponsive to treatment. - Sudden loss of vision. - Corneal ulceration or infection.

Before prescribing Latanoprost, clinicians should evaluate patient history and monitor ocular health. - Monitor intra‑ocular pressure: assess response after initiation and adjust therapy as needed. - Assess for ocular infections: avoid use in active conjunctivitis or keratitis. - Use with caution in patients with a history of uveitis or ocular inflammation. - Avoid concurrent use with other prostaglandin analog eye drops to prevent additive effects. - Pregnancy and lactation: safety not established; use only if benefit outweighs risk. - Store at ambient temperature: keep in original container, protect from light and moisture.

Latanoprost can interact with other ophthalmic agents, affecting efficacy or safety.

Major Interactions (Avoid): - Concomitant use with other prostaglandin analog eye drops: may cause excessive IOP reduction. - Use with preservative‑containing NSAID eye drops: increased risk of ocular irritation.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: additive intra‑ocular pressure‑lowering effect. - Topical corticosteroids: may diminish Latanoprost efficacy. - Anticholinergic eye drops: possible reduction in tear production, leading to discomfort. - Systemic carbonic anhydrase inhibitors: monitor IOP for synergistic lowering.